Genocea Biosciences
About:
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Website: http://www.genocea.com
Twitter/X: GenoceaBio
Top Investors: Alexandria Real Estate Equities, Bill & Melinda Gates Foundation, Polaris Partners, SR One, Lux Capital
Description:
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs.Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.
$521M
$10M to $50M
Cambridge, Massachusetts, United States
2006-01-01
website.inquiry(AT)genocea.com
Chip Clark, Darren Higgins, David Sinclair, Josh Wolfe, Kevin Bitterman
51-100
2020-07-22
Public
© 2025 bioDAO.ai